-
EP3212670
European procedure
Extract from the Register of European Patents
EP Citations: EP3212670
| Cited in | International search | Type: | Patent literature | Publication No.: | WO2013132044
[Y] (HOFFMANN LA ROCHE et al.) | Type: | Patent literature | Publication No.: | US2013309250
[Y] (COGSWELL JOHN et al.) | Type: | Patent literature | Publication No.: | US2011274683
[Y] (WONG JUSTIN et al.) | Type: | Patent literature | Publication No.: | US2015073129
[XPI] (HERTING FRANK et al.) | Type: | Non-patent literature | Publication information: | [IDY] Y. ZHU ET AL: "CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models", CANCER RESEARCH, vol. 74, no. 18, 31 July 2014 (2014-07-31), US, pages 5057 - 5069, XP055242334, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-13-3723 | DOI: | http://dx.doi.org/10.1158/0008-5472.CAN-13-3723 | Type: | Non-patent literature | Publication information: | [YD] RIES CAROLA H ET AL: "Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy", CANCER CELL, vol. 25, no. 6, 16 June 2014 (2014-06-16), pages 846 - 859, XP028855510, ISSN: 1535-6108, DOI: 10.1016/J.CCR.2014.05.016 | DOI: | http://dx.doi.org/10.1016/j.ccr.2014.05.016 | Type: | Non-patent literature | Publication information: | [XPI] CAROLA H RIES ET AL: "CSF-1/CSF-1R targeting agents in clinical development for cancer therapy", CURRENT OPINION IN PHARMACOLOGY, vol. 23, 1 August 2015 (2015-08-01), NL, pages 45 - 51, XP055243143, ISSN: 1471-4892, DOI: 10.1016/j.coph.2015.05.008 | DOI: | http://dx.doi.org/10.1016/j.coph.2015.05.008 | Type: | Non-patent literature | Publication information: | [XPI] ANONYMOUS: "Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types", 24 November 2014 (2014-11-24), pages 1 - 4, XP055243984, Retrieved from the Internet | Type: | Non-patent literature | Publication information: | [XPI] ANONYMOUS: "Study of FPA008 in Combination With Nivolumab in Patients With Selected Advance Cancers", CLINICALTRIALS.GOV, 17 August 2015 (2015-08-17), pages 1 - 4, XP055243978, Retrieved from the Internet | Cited in | by applicant | Type: | Patent literature | Publication No.: | US7943743
| Type: | Patent literature | Publication No.: | WO2013173223
| Type: | Patent literature | Publication No.: | US8217149
| Type: | Patent literature | Publication No.: | WO2004113304
| Type: | Patent literature | Publication No.: | US5530101
| Type: | Patent literature | Publication No.: | US5585089
| Type: | Patent literature | Publication No.: | US5693761
| Type: | Patent literature | Publication No.: | US5693762
| Type: | Patent literature | Publication No.: | US6180370
| Type: | Patent literature | Publication No.: | US2009136500
| Type: | Patent literature | Publication No.: | US4816567
| Type: | Patent literature | Publication No.: | US5545807
| Type: | Patent literature | Publication No.: | US6713610
| Type: | Patent literature | Publication No.: | US6673986
| Type: | Patent literature | Publication No.: | US6162963
| Type: | Patent literature | Publication No.: | US6300129
| Type: | Patent literature | Publication No.: | US6255458
| Type: | Patent literature | Publication No.: | US5877397
| Type: | Patent literature | Publication No.: | US5874299
| Type: | Patent literature | Publication No.: | US5545806
| Type: | Patent literature | Publication No.: | WO9910494
| Type: | Patent literature | Publication No.: | US8206715
| Type: | Patent literature | Publication No.: | US8008449
| Type: | Patent literature | Publication No.: | US6808710
| Type: | Patent literature | Publication No.: | US7488802
| Type: | Patent literature | Publication No.: | US8168757
| Type: | Patent literature | Publication No.: | US8354509
| Type: | Patent literature | Publication No.: | WO2012145493
| Type: | Patent literature | Publication No.: | US8900587
| Type: | Patent literature | Publication No.: | US8609089
| Type: | Patent literature | Publication No.: | WO2006081430
| Type: | Patent literature | Publication No.: | WO2006076288
| Type: | Patent literature | Publication No.: | US2006270045
| Type: | Patent literature | Publication No.: | EP1125584
| Type: | Patent literature | Publication No.: | WO2011140249
| Type: | Non-patent literature | Publication information: | LIN ET AL., SCIENCE, vol. 320, 2008, pages 807 - 11 | Type: | Non-patent literature | Publication information: | PAULUS ET AL., CANCER RES., vol. 66, 2006, pages 4349 - 56 | Type: | Non-patent literature | Publication information: | OHNO ET AL., MOL. CANCER THER., vol. 5, 2006, pages 2634 - 43 | Type: | Non-patent literature | Publication information: | RIES ET AL., CANCER CELL, vol. 25, 2014, pages 846 - 859 | Type: | Non-patent literature | Publication information: | PYONTECH ET AL., NATURE MED., vol. 19, 2013, pages 1264 - 1272 | Type: | Non-patent literature | Publication information: | ZHU ET AL., CANCER RES., vol. 74, 2014, pages 5057 - 5069 | Type: | Non-patent literature | Publication information: | SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual, 2nd ed.", 1989, COLD SPRING HARBOR LABORATORY PRESS | Type: | Non-patent literature | Publication information: | ANGAL ET AL., MOL. IMMUNOL., vol. 30, 1993, pages 105 - 108 | Type: | Non-patent literature | Publication information: | BLOOM ET AL., PROT. SCI., vol. 6, 1997, pages 407 - 415 | Type: | Non-patent literature | Publication information: | SCHUURMAN ET AL., MOL. IMMUNOL., vol. 38, 2001, pages 1 - 8 | Type: | Non-patent literature | Publication information: | KABAT: "Sequences of Proteins of Immunological Interest", 1987, NIH | Type: | Non-patent literature | Publication information: | AGNEW, CHEM INTL. ED. ENGL., vol. 33, 1994, pages 183 - 186 | Type: | Non-patent literature | Publication information: | KLAGSBRUN; D'AMORE, ANNU. REV. PHYSIOL., vol. 53, 1991, pages 217 - 39 | Type: | Non-patent literature | Publication information: | STREIT; DETMAR, ONCOGENE, vol. 22, 2003, pages 3172 - 3179 | Type: | Non-patent literature | Publication information: | FERRARA; ALITALO, NATURE MEDICINE, vol. 5, no. 12, 1999, pages 1359 - 1364 | Type: | Non-patent literature | Publication information: | TONINI ET AL., ONCOGENE, vol. 22, 2003, pages 6549 - 6556 | Type: | Non-patent literature | Publication information: | SATO, INT. J. CLIN. ONCOL., vol. 8, 2003, pages 200 - 206 | Type: | Non-patent literature | Publication information: | MURAKAMI ET AL.: "The Molecular Basis of Cancer", 1995, W.B. SAUNDERS, article "Cell cycle regulation, oncogenes, and antineoplastic drugs", pages: 13 | Type: | Non-patent literature | Publication information: | JONES ET AL., NATURE, vol. 321, 1986, pages 522 - 525 | Type: | Non-patent literature | Publication information: | RIECHMANN ET AL., NATURE, vol. 332, 1988, pages 323 - 27 | Type: | Non-patent literature | Publication information: | VERHOEYEN ET AL., SCIENCE, vol. 239, 1988, pages 1534 - 36 | Type: | Non-patent literature | Publication information: | MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 6851 - 55 | Type: | Non-patent literature | Publication information: | JAKOBOVITS ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 2551 - 55 | Type: | Non-patent literature | Publication information: | JAKOBOVITS ET AL., NATURE, vol. 362, 1993, pages 255 - 8 | Type: | Non-patent literature | Publication information: | LONBERG ET AL., NATURE, vol. 368, 1994, pages 856 - 9 | Type: | Non-patent literature | Publication information: | HOOGENBOOM ET AL., J. MOL. BIOL., vol. 227, 1992, pages 381 - 8 | Type: | Non-patent literature | Publication information: | MARKS ET AL., J. MOL. BIOL., vol. 222, 1991, pages 581 - 97 | Type: | Non-patent literature | Publication information: | HOSSE ET AL., PROT. SCI., vol. 15, 2006, pages 14 | Type: | Non-patent literature | Publication information: | FIEDLER, M.; SKERRA, A.: "Handbook of Therapeutic Antibodies", 2007, WILEY-VCH, article "Non-Antibody Scaffolds", pages: 467 - 499 | Type: | Non-patent literature | Publication information: | WANG ET AL., CANCER IMMUNOL RES., vol. 2, no. 9, 2014, pages 846 - 56 | Type: | Non-patent literature | Publication information: | CHOO ET AL., BMC BIOINFORMATICS, vol. 6, 2005, pages 249 | Type: | Non-patent literature | Publication information: | RUNNING DEER ET AL., BIOTECHNOL. PROG., vol. 20, 2004, pages 880 - 889 | Type: | Non-patent literature | Publication information: | SAMBROOK ET AL.: "Molecular Cloning, A Laboratory Manual, 3rd ed.", 2001, COLD SPRING HARBOR LABORATORY PRESS | Type: | Non-patent literature | Publication information: | SITARAMAN ET AL., METHODS MOL. BIOL., vol. 498, 2009, pages 229 - 244 | Type: | Non-patent literature | Publication information: | SPIRIN, TRENDS BIOTECHNOL., vol. 22, 2004, pages 538 - 545 | Type: | Non-patent literature | Publication information: | ENDO ET AL., BIOTECHNOL. ADV., vol. 21, 2003, pages 695 - 713 | Type: | Non-patent literature | Publication information: | TANG ET AL., NATURE, vol. 356, 1992, pages 152 - 154 | Type: | Non-patent literature | Publication information: | GENNARO: "Remington: The Science and Practice of Pharmacy with Facts and Comparisons: Drugfacts Plus, 20th ed.", 2003 | Type: | Non-patent literature | Publication information: | ANSEL ET AL.: "Pharmaceutical Dosage Forms and Drug Delivery Systems", 2004, LIPPENCOTT WILLIAMS AND WILKINS | Type: | Non-patent literature | Publication information: | KIBBE ET AL.: "Handbook of Pharmaceutical Excipients, 3rd ed.", 2000, PHARMACEUTICAL PRESS | Type: | Non-patent literature | Publication information: | ANSARI MJ; SALAMA AD; CHITNIS T; SMITH RN; YAGITA H; AKIBA H ET AL.: "The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice", J EXP MED., vol. 198, no. 1, 2003, pages 63 - 9, XP055188563, DOI: doi:10.1084/jem.20022125 | DOI: | http://dx.doi.org/10.1084/jem.20022125 | Type: | Non-patent literature | Publication information: | BLAZAR BR; CARRENO BM; PANOSKALTSIS-MORTARI A; CARTER L; IWAI Y; YAGITA H ET AL.: "Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-a-dependent mechanism", J IMMUNOL., vol. 171, 2003, pages 1272 - 7 | Type: | Non-patent literature | Publication information: | CARTER LL; FOUSER LA; JUSSIF J; FITZ L; DENG B; WOOD CR ET AL.: "PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2", EUR J IMMUNOL., vol. 32, no. 3, 2002, pages 634 - 43, XP002980901, DOI: doi:10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9 | DOI: | http://dx.doi.org/10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9 | Type: | Non-patent literature | Publication information: | CASSIER P; GOMEZ-ROCA C; ITALIANO A; CANNARILE M; RIES C; BRILLOUET A ET AL.: "Phase 1 study of RG7155, a novel anti-CSFIR antibody, in patients with locally advanced pigmented villonodular synovitis (PVNS", J CLIN ONCOL SUPPL., vol. 32, pages 5 | Type: | Non-patent literature | Publication information: | CHEMNITZ JM; PARRY RV; NICHOLS KE; JUNE CH; RILEY JL: "SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation", J IMMUNOL., vol. 173, 2004, pages 945 - 54 | Type: | Non-patent literature | Publication information: | DAI X; RYAN G; HAPEL A; DOMINGUEZ M; RUSSELL R; KAPP S ET AL.: "Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects", BLOOD, vol. 99, 2002, pages 111 - 20, XP002505054, DOI: doi:10.1182/blood.V99.1.111 | DOI: | http://dx.doi.org/10.1182/blood.V99.1.111 | Type: | Non-patent literature | Publication information: | DUNN GP; BRUCE AT; IKEDA H; OLD LJ; SCHREIBER RD: "Cancer immunoediting: from immunosurveillance to tumor escape", NAT IMMUNOL., vol. 3, 2002, pages 991 - 8 | Type: | Non-patent literature | Publication information: | FREEMAN GJ; LONG AJ; IWAI Y; BOURQUE K; CHERNOVA T; NISHIMURA H ET AL.: "Engagement of the PD 1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation", J EXP MED., vol. 192, no. 7, 2000, pages 1027 - 34 | Type: | Non-patent literature | Publication information: | GABBAY MB; THOMAS J; GIBBS A; HOLD P: "A randomized crossover trial of the impact of additional spermicide on condom failure rates", SEX TRANSM DIS., vol. 35, 2008, pages 862 - 8 | Type: | Non-patent literature | Publication information: | GREENWALD RJ; FREEMAN GH; SHARPE AH: "The B7 family revisited", ANNU REV IMMUNOL., vol. 23, 2004, pages 515 - 48 | Type: | Non-patent literature | Publication information: | HABICHT A; DADA S; JUREWICZ M; FIFE BT; YAGITA H; AZUMA M ET AL.: "A link between PDL1 and T regulatory cells in fetomaternal tolerance", J IMMUNOL., vol. 179, 2007, pages 5211 - 9 | Type: | Non-patent literature | Publication information: | HAMILTON J; ACHUTHAN A: "Colony stimulating factors and myeloid cell biology in health and disease", TRENDS IN IMMUNOLOGY, vol. 34, 2013, pages 81 - 89, XP002712628, DOI: doi:10.1016/j.it.2012.08.006 | DOI: | http://dx.doi.org/10.1016/j.it.2012.08.006 | Type: | Non-patent literature | Publication information: | KAUFMANN DE; WALKER BD: "Programmed death-1 as a factor in immune exhaustion and activation in HIV infection", CURR OPIN HIV AIDS, vol. 3, no. 3, 2008, pages 362 - 7 | Type: | Non-patent literature | Publication information: | KESTELMAN P; TRUSSEL, J: "Efficacy of the simultaneous use of condoms and spermicides", FAMILY PLANNING PERSPECTIVES, vol. 23, no. 5, 1991, pages 226 - 7 | Type: | Non-patent literature | Publication information: | KOMOHARA Y; JINUSHI M; TAKEYA M: "Clinical significance of macrophage heterogeneity in human malignant tumors", CANCER SCI., vol. 105, 2014, pages 1 - 8 | Type: | Non-patent literature | Publication information: | KUANG DM; ZHAO Q; PENG C; XU J; ZHANG JP; WU C ET AL.: "Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1", J EXP MED., vol. 206, no. 6, 2009, pages 1327 - 37 | Type: | Non-patent literature | Publication information: | LATCHMAN Y; WOOD CR; CHERNOVA T; CHAUDHARY D; BORDE M; CHERNOVA I ET AL.: "PD-L2 is a second ligand for PD-1 and inhibits T cell activation", NAT IMMUNOL., vol. 2, no. 3, 2001, pages 261 - 268, XP001064842, DOI: doi:10.1038/85330 | DOI: | http://dx.doi.org/10.1038/85330 | Type: | Non-patent literature | Publication information: | LAVIN Y; MERAD M: "Macrophages: gatekeepers of tissue integrity", CANCER IMMUNOL RES., vol. 1, no. 4, 2013, pages 201 - 9 | Type: | Non-patent literature | Publication information: | LAVIN Y; WINTER D; BLECHER-GONEN R; DAVID E; KEREN-SHAUL H; MERAD M ET AL.: "Tissue-dependent macrophage enhancer landscapes are shaped by the local microenvironment", CELL, vol. 159, 2014, pages 1312 - 26, XP029110667, DOI: doi:10.1016/j.cell.2014.11.018 | DOI: | http://dx.doi.org/10.1016/j.cell.2014.11.018 | Type: | Non-patent literature | Publication information: | LLOSA NJ; CRUISE M; TAM A; WICKS EC; HECHENBLEIKNER EM; TAUBE JM ET AL.: "The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints", CANCER DISCOV., vol. 5, no. L, 2015, pages 43 - 51, XP055390935, DOI: doi:10.1158/2159-8290.CD-14-0863 | DOI: | http://dx.doi.org/10.1158/2159-8290.CD-14-0863 | Type: | Non-patent literature | Publication information: | MASTELLER E; WONG, B: "Targeting IL-34 in chronic inflammation", DRUG DISCOV TODAY, vol. 19, 2014, pages 1212 - 16, XP055212562, DOI: doi:10.1016/j.drudis.2014.05.016 | DOI: | http://dx.doi.org/10.1016/j.drudis.2014.05.016 | Type: | Non-patent literature | Publication information: | NISHIMURA H; NOSE M; HIAI H; MINATO N; HONJO T: "Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor", IMMUNITY, vol. 11, 1999, pages 141 - 51, XP000971788, DOI: doi:10.1016/S1074-7613(00)80089-8 | DOI: | http://dx.doi.org/10.1016/S1074-7613(00)80089-8 | Type: | Non-patent literature | Publication information: | NISHIMURA H; HONJO T: "PD-1: an inhibitory immunoreceptor involved in peripheral tolerance", TRENDS IMMUNOL., vol. 22, 2001, pages 265 - 8, XP004235272, DOI: doi:10.1016/S1471-4906(01)01888-9 | DOI: | http://dx.doi.org/10.1016/S1471-4906(01)01888-9 | Type: | Non-patent literature | Publication information: | NISHIMURA H; OKAZAKI T; TANAKA Y; NAKATANI K; HARA M; MATSUMORI A ET AL.: "Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice", SCIENCE, vol. 291, 2001, pages 319 - 22 | Type: | Non-patent literature | Publication information: | NIVOLUMAB INVESTIGATOR'S BROCHURE. VERSION 13. BRISTOL-MYERS SQUIBB, 21 July 2014 (2014-07-21) | Type: | Non-patent literature | Publication information: | NOY R; POLLARD J: "Tumor-associated macrophages: from mechanisms to therapy", IMMUNITY, vol. 41, 2014, pages 49 - 61 | Type: | Non-patent literature | Publication information: | OKAZAKI T; TANAKA Y; NISHIO R; MITSUIYE T; MIZOGUCHI A; WANG J ET AL.: "Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice", NAT MED., vol. 9, 2003, pages 1477 - 83, XP002376772, DOI: doi:10.1038/nm955 | DOI: | http://dx.doi.org/10.1038/nm955 | Type: | Non-patent literature | Publication information: | "Opdivo [package insert", March 2015, BRISTOL-MYERS SQUIBB COMPANY | Type: | Non-patent literature | Publication information: | PARDOLL D: "Does the immune system see tumors as foreign or self?", ANNU REV IMMUNOL., vol. 21, 2003, pages 807 - 39 | Type: | Non-patent literature | Publication information: | PYONTECK S; AKKARI L; SCHUHMACHER A; BOWMAN R; SEVENICH L; QUAIL D ET AL.: "CSF-1R inhibition alters macrophage polarization and blocks glioma progression", NAT MED., vol. 19, 2013, pages 1264 - 72 | Type: | Non-patent literature | Publication information: | RADI Z; GUZMAN R; BELL R: "Increased connective tissue extracellular matrix in the op/op model of osteopetrosis", PATHOBIOLOGY, vol. 76, 2009, pages 199 - 203 | Type: | Non-patent literature | Publication information: | RADI Z; KOZA-TAYLOR P; BELL R; OBERT L; RUNNELS H; BEEBE J ET AL.: "Increased serum enzyme levels associated with Kupffer cell reduction with no signs of hepatic or skeletal muscle injury", AM J PATHOL., vol. 179, 2011, pages 240 - 247 | Type: | Non-patent literature | Publication information: | RIES C; CANNARILE M; HOVES S; BENZ J; WARTHA K; RUNZA V ET AL.: "Targeting tumor-associated macrophages with anti-CSF-lR antibody reveals a strategy for cancer therapy", CANCER CELL, vol. 25, 2014, pages 846 - 59, XP028855510, DOI: doi:10.1016/j.ccr.2014.05.016 | DOI: | http://dx.doi.org/10.1016/j.ccr.2014.05.016 | Type: | Non-patent literature | Publication information: | RIZVI NA; MAZEIRES J; PLANCHARD D; STINCHCOMBE TE; DY GK; ANTONIA SJ ET AL.: "Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial", LANCET ONCOL., vol. 16, no. 3, 2015, pages 257 - 65 | Type: | Non-patent literature | Publication information: | RUFFELL B; COUSSENS LM: "Macrophages and therapeutic resistance in cancer", CANCER CELL, vol. 27, 2015, pages 462 - 72 | Type: | Non-patent literature | Publication information: | RUTEBEMBERWA A; RAY SC; ASTEMBORSKI JL; LEVINE J; LIU L; DOWD KA ET AL.: "High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection", J IMMUNOL., vol. 181, 2008, pages 8215 - 25 | Type: | Non-patent literature | Publication information: | SADIS S; MUKHERJEE A; OLSON S; DOKMANOVICH M; MAHER R; CAI C ET AL.: "Safety, pharmacokinetics, and pharmacodynamics of PD-0360324, a human monoclonal antibody to monocyte/macrophage colony stimulating factor, in healthy volunteers", ACR/ARHP SCIENTIFIC MEETING, 17 October 2009 (2009-10-17) | Type: | Non-patent literature | Publication information: | SALAMA AD; CHITNIS T; IMITOLA J; ANSARI MJ; AKIBA H; TUSHIMA F ET AL.: "Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis", J EXP MED., vol. 198, 2003, pages 71 - 8, XP055014704, DOI: doi:10.1084/jem.20022119 | DOI: | http://dx.doi.org/10.1084/jem.20022119 | Type: | Non-patent literature | Publication information: | SHARPE AH; WHERRY EJ; AHMED R; FREEMAN GJ: "The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection", NATURE IMMUNOL., vol. 8, 2007, pages 239 - 45 | Type: | Non-patent literature | Publication information: | SHEPPARD KA; FITZ LJ; LEE JM; BENANDER C; GEORGE JA; WOOTERS J ET AL.: "PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKC-theta", FEBS LETTERS, vol. 574, 2004, pages 37 - 41, XP004557234, DOI: doi:10.1016/j.febslet.2004.07.083 | DOI: | http://dx.doi.org/10.1016/j.febslet.2004.07.083 | Type: | Non-patent literature | Publication information: | TUMEH PC; HARVIEW CL; YEARLEY JH; SHINTAKU IP; TAYLOR EJM; ROBERT L ET AL.: "PD-1 blockade induces responses by inhibiting adaptive immune resistance", NATURE, vol. 515, 2014, pages 568 - 71, XP055247294, DOI: doi:10.1038/nature13954 | DOI: | http://dx.doi.org/10.1038/nature13954 | Type: | Non-patent literature | Publication information: | VELU V; TITANJI K; ZHU B; HUSAIN S; PLADEVEGA A; LAI L ET AL.: "Enhancing SIV-specific immunity in vivo by PD-1 blockade", NATURE, vol. 458, 2009, pages 206 - 10 | Type: | Non-patent literature | Publication information: | WANG C; THUDIUM KB; HAN M; WANG XT; HUANG H; FEINGERSH D ET AL.: "In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates", CANCER IMMUNOL RES., vol. 2, 2014, pages 846 - 56, XP055206944, DOI: doi:10.1158/2326-6066.CIR-14-0040 | DOI: | http://dx.doi.org/10.1158/2326-6066.CIR-14-0040 | Type: | Non-patent literature | Publication information: | WEBER JS; D'ANGELO SP; MINOR D; HODI FS; GUTZMER R; NEYNS B ET AL.: "Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial", LANCET ONCOL., vol. 16, no. 4, 2015, pages 375 - 84 | Type: | Non-patent literature | Publication information: | WOLCHOK JD; HOOS A; O'DAY S; WEBER JS; HAMID O; LEBBE C: "Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria", CLIN CANCER RES., vol. 15, 2009, pages 7412 - 20 | Type: | Non-patent literature | Publication information: | ZITVOGEL L; TESNIERE A; KROEMER G: "Cancer despite immunosurveillance: immunoselection and immunosubversion", NAT REV IMMUNOL., vol. 6, 2006, pages 715 - 27, XP002440492, DOI: doi:10.1038/nri1936 | DOI: | http://dx.doi.org/10.1038/nri1936 | Type: | Non-patent literature | Publication information: | ZHU Y; KNOLHOFF B; MEYER M; NYWENING T; WEST B; LUO J ET AL.: "CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models", CANCER RES., vol. 74, 2014, pages 5057 - 69, XP055242334, DOI: doi:10.1158/0008-5472.CAN-13-3723 | DOI: | http://dx.doi.org/10.1158/0008-5472.CAN-13-3723 |